Thoracic epidural analgesia | p Value | ||
No | Yes | ||
n=50 | n=50 | ||
Age, years | 80±9 | 78±8 | 0.281 |
Males | 22 (44.0) | 18 (36.0) | 0.541 |
Diabetes | 17 (34.0) | 19 (38.0) | 0.835 |
Dyslipidemia | 42 (84.0) | 43 (86.0) | 1.00 |
Hypertension | 47 (94.0) | 47 (94.0) | 1.00 |
Coronary artery disease | 33 (66.0) | 35 (70.0) | 0.831 |
Previous myocardial infarction | 23 (46.0) | 21 (42.0) | 0.841 |
Previous atrial fibrillation | 15 (30.0) | 13 (26.0) | 0.824 |
Prior CABG | 21 (42.0) | 18 (36.0) | 0.682 |
Prior stroke | 2 (4.0) | 4 (8.0) | 0.678 |
Peripheral vascular disease | 19 (38.0) | 27 (54.0) | 0.160 |
COPD | 16 (32.0) | 16 (32.0) | 1.00 |
eGFR <60 ml/min | 31 (62.0) | 35 (70.0) | 0.527 |
STS-PROM score (%) | 9.1±5.5 | 8.4±3.8 | 0.567 |
Frailty | 8 (16.0) | 9 (18.0) | 1.00 |
Severely calcified or porcelain aorta | 14 (28.0) | 16 (32.0) | 0.828 |
Mean aortic gradient (mm Hg) | 42.3±16.6 | 40.4±17.0 | 0.566 |
Aortic valve area (cm2) | 0.62±0.16 | 0.67±0.23 | 0.266 |
LVEF (%) | 55±13 | 54±12 | 0.809 |
LVEF<40 | 6 (12.0) | 9 (18.0) | 0.579 |
SPAP (mm Hg) | 46±13 | 43±13 | 0.403 |
Moderate/severe mitral regurgitation | 19 (38.0) | 14 (28.0) | 0.395 |
Values are mean±SD, n (%).
CABG, coronary artery bypass graft; COPD, chronic obstructive pulmonary disease; eGFR, estimated glomerularfiltration rate; LVEF, left ventricular ejection fraction; PAP, systolic pulmonary artery pressure; STS-PROM, Society of Thoracic Surgeons predicted risk of mortality.